Nucleolar Delocalization of Human Topoisomerase I in Response to Topotecan Correlates with Sumoylation of the Protein
Open Access
- 1 January 2002
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 277 (4), 2958-2964
- https://doi.org/10.1074/jbc.m108263200
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Tumor Cell Death Induced by Topoisomerase-Targeting DrugsAnnual Review of Pharmacology and Toxicology, 2001
- A Novel Nuclear Localization Signal in Human DNA Topoisomerase IOnline Journal of Public Health Informatics, 2000
- Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3Journal of Biological Chemistry, 2000
- Structure and Function in the NucleusScience, 1998
- Modification of Ran GTPase-activating Protein by the Small Ubiquitin-related Modifier SUMO-1 Requires Ubc9, an E2-type Ubiquitin-conjugating Enzyme HomologueOnline Journal of Public Health Informatics, 1998
- Alteration of the Nucleolar Localization of Poly(ADP-ribose) Polymerase upon Treatment with Transcription InhibitorsExperimental Cell Research, 1996
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- The Domain Organization of Human Topoisomerase IOnline Journal of Public Health Informatics, 1996
- Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopyCytometry, 1995
- cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.Proceedings of the National Academy of Sciences of the United States of America, 1988